The ratio has increased, as 114 investment managers opened new and increased holdings, while 88 sold and reduced their holdings in Athenahealth Inc. The stock of athenahealth, Inc. (NASDAQ:ATHN) for 182 shares. (NASDAQ:ATHN) on Tuesday, May 8 to "Outperform" rating. Hull Brandon H also sold $107,896 worth of athenahealth, Inc. The company has a current ratio of 2.71, a quick ratio of 2.71 and a debt-to-equity ratio of 0.25. Allianz Asset Management GmbH now owns 555,766 shares of the health services provider's stock worth $73,939,000 after purchasing an additional 223,006 shares in the last quarter. Quantitative Mgmt Lc reported 14,400 shares or 0.04% of all its holdings. Lpl Ltd Liability Corp has invested 0% of its portfolio in athenahealth, Inc.
Barton Investment Management holds 5.7% of its portfolio in athenahealth, Inc. for 174,894 shares. (NASDAQ:ATHN) or 3,139 shares. Tokio Marine Asset Management Ltd invested in 0.2% or 7,800 shares. Gagnon Securities Llc, a New York-based fund reported 37,816 shares. Summit Trail Advisors LLC raised its stake in shares of athenahealth by 13,481.3% in the first quarter. Also, the number of hedge funds holding Caci International Inc in their top 10 holdings increased from 0 to 2 for an increase of 2. (NASDAQ:ATHN) or 150 shares. He is also facing allegations of inappropriate workplace conduct. $252,485 worth of athenahealth, Inc. Another trade for 150 shs valued at $21,512 was sold by Porter Jonathan D. On Tuesday, January 2 the insider ROBINSON DAVID ERIC sold $669,698. Monness Crespi & Hardt, on the other hand, Initiated a "Buy" rating on this stock, while posting a $51 price target on shares of this company's stock in a research note dated Wednesday, April 11th, 2018. The PT means a possible upside of 1.91 % from firm's previous close. Out of 17 Wall Street analysts rating Athenahealth, 5 give it "Buy", 0 "Sell" rating, while 12 recommend "Hold".
Ratings analysis reveals 29% of Athenahealth's analysts are positive. 33% are bullish. With $179 highest and $130.0 lowest target Athenahealth has $154.28 average target or -2.13% below the current ($157.635) price. The stock presently has an average rating of "Hold" and a consensus target price of $152.64. Athenahealth had 27 analyst reports since December 8, 2017 according to SRatingsIntel. The firm has "Hold" rating given on Monday, February 5 by Canaccord Genuity. JP Morgan maintained it with "Neutral" rating and $159 target in Tuesday, April 24 report. $64,693 worth of athenahealth, Inc. (NASDAQ:ATHN) shs. On Thursday, February 1 Bush Jonathan sold $613,427 worth of athenahealth, Inc. The rating was maintained by Stifel Nicolaus on Thursday, February 1 with "Buy". (NASDAQ:ATHN) has "Hold" rating given by Cantor Fitzgerald. In Tuesday, May 22 report Deutsche Bank maintained the stock with "Hold" rating. The firm has "Hold" rating by Cantor Fitzgerald given on Tuesday, February 20. Jefferies maintained athenahealth, Inc. (NASDAQ:ATHN) rating on Wednesday, February 7.
Prior to athenahealth, Levine most recently served as the executive vice president and CFO of JDA Software Group, Inc., a privately-held supply chain provider of software and SaaS solutions, where he led the company's finance and accounting, legal, workplace, purchasing and information technology activities. ATHN is uptrending and has moved 14.89% since June 6, 2017. The stock outperformed the S&P500 by 2.32%. (NASDAQ:ATHN). Cambiar has invested 0.11% in athenahealth, Inc. (NASDAQ:ATHN) to report earnings on July, 19. They expect $0.62 earnings per share, up 121.43 % or $0.34 from last year's $0.28 per share. CACI's profit will be $40.75M for 25.48 P/E if the $1.65 EPS becomes a reality. After $0.99 actual EPS reported by athenahealth, Inc. for the previous quarter, Wall Street now forecasts -37.37 % negative EPS growth.
Meanwhile, the company is mulling over a almost $7 billion takeover offer from Elliott Management. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services. The company has a market cap of $6.03 billion, a PE ratio of 96.28, a PEG ratio of 2.78 and a beta of 1.26.